Abstract
Selective-Serotonin Reuptake Inhibitors (SSRIs) are widely prescribed for the pharmacotherapy of mood disorders and gained much attention for their sexual side-effects. Previous research has shown that antidepressant induced sexual dysfunction may persist upon discontinuation of the therapy, which in turn negatively influences Quality of Life (QoL). As no quantitative studies
... read more